Free account + included starter software — credential review typically takes 1–2 business days. See how it works
SALICYLIC ACID WART REMOVER 0.275 10 ML - 275 mg/mL LIQUID
Request Item

SALICYLIC ACID WART REMOVER 0.275 10 ML

Generic: SALICYLIC ACID

SALICYLIC ACID WART REMOVER 0.275 10 ML

NDC:42192-0135-10
Manufacturer:Acella Pharmaceuticals, LLC
Strength:275 mg/mL
Dosage Form:LIQUID
Route:TOPICAL

Sign up to see pricing

Licensed pharmacies, clinics, doctor's offices, and veterinary practices get instant account approval

Sign Up — Instant Approval

Drug Information

Identification

Generic Name

SALICYLIC ACID

Brand Name

SALICYLIC ACID

Labeler / Distributor

Acella Pharmaceuticals, LLC

Product Type

HUMAN PRESCRIPTION DRUG

Administration

Dosage Form

LIQUID

Route of Administration

TOPICAL

Active Ingredients

IngredientStrength
SALICYLIC ACID275 mg/mL

Data sourced from openFDA / DailyMed. For full prescribing information, consult the drug label.

Clinical Drug Information

Indications & Usage

INDICATIONS AND USES: Salicylic Acid, 27.5% Wart Remover is indicated for the topical treatment and removal of common warts and plantar warts.

Dosage & Administration

DOSAGE AND ADMINISTRATION: Prior to application of Salicylic Acid, 27.5% Wart Remover, soak wart in warm water for five minutes. Remove any loosened tissue by gently rubbing with a brush, wash cloth or emery board. Dry thoroughly. Using the brush applicator supplied, apply twice to entire wart surface, allowing the first application to dry before applying the second. Treatment should be once or twice a day and should continue as directed by physician. Be careful not to apply to surrounding skin. Clinically visible improvement will normally occur during the first or second week of therapy. Maximum resolution may be expected after four to six weeks of use.

Adverse Reactions

ADVERSE REACTIONS: A localized irritant reaction may occur if Salicylic Acid, 27.5% Wart Remover is applied to the normal skin surrounding the wart. Any irritation may normally be controlled by temporarily discontinuing use and by applying the medication only to the wart site when treatment is resumed.

Clinical data sourced from openFDA drug labeling. For complete prescribing information, consult the full drug label.